{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T13:56:15Z","timestamp":1793973375538,"version":"4.8.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004606","name":"Chang Gung Medical Foundation","doi-asserted-by":"publisher","award":["CMRPG3N0521"],"award-info":[{"award-number":["CMRPG3N0521"]}],"id":[{"id":"10.13039\/501100004606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ijrobp.2023.09.049","type":"journal-article","created":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T20:56:12Z","timestamp":1696020972000},"page":"712-724","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Clinical and Dosimetric Results of Proton or Photon Radiation Therapy for Large (&gt;5 cm) Hepatocellular Carcinoma: A Retrospective Analysis"],"prefix":"10.1016","volume":"118","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2038-4537","authenticated-orcid":false,"given":"Rodney Cheng-En","family":"Hsieh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Hsin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiao-Chieh","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Yu","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Ping","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Wei","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhanu Prasad","family":"Venkatesulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Chiao","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Chih","family":"Chou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun-Ming","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Ting","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Chen","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Chun","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen-Yen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Hong","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2023.09.049_bib0001","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jhep.2019.08.025","article-title":"Epidemiology and surveillance for hepatocellular carcinoma: New trends","volume":"72","author":"Singal","year":"2020","journal-title":"J Hepatology"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0002","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/jamaoncol.2017.3055","article-title":"Global Burden of Disease Liver Cancer Collaboration. The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: Results from the Global Burden of Disease Study 2015","volume":"3","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0003","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0004","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.29086","article-title":"AASLD guidelines for the treatment of hepatocellular carcinoma","volume":"67","author":"Heimbach","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0005","article-title":"Clinical characteristics and prognosis of 2887 patients with hepatocellular carcinoma: A single center 14 years experience from China","volume":"98","author":"Wang","year":"2019","journal-title":"Medicine"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0006","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1002\/cam4.1493","article-title":"Prognosis of patients with hepatocellular carcinoma treated with sorafenib: A comparison of five models in a large Canadian database","volume":"7","author":"Samawi","year":"2018","journal-title":"Cancer Med"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0007","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ijrobp.2019.12.004","article-title":"Curative irradiation treatment of hepatocellular carcinoma: A multicenter phase 2 trial","volume":"107","author":"Durand-Labrunie","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0008","doi-asserted-by":"crossref","first-page":"djw133","DOI":"10.1093\/jnci\/djw133","article-title":"Radiotherapy for hepatocellular carcinoma: New indications and directions for future study","volume":"108","author":"Ohri","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0009","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.semradonc.2017.04.002","article-title":"Radiation-induced liver toxicity","volume":"27","author":"Munoz-Schuffenegger","year":"2017","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0010","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.ijrobp.2009.06.092","article-title":"Radiation-associated liver injury","volume":"76","author":"Pan","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0011","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.prro.2015.01.004","article-title":"Clinical decision tool for optimal delivery of liver stereotactic body radiation therapy: Photons versus protons","volume":"5","author":"Gandhi","year":"2015","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0012","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1748-717X-8-48","article-title":"What is the appropriate size criterion for proton radiotherapy for hepatocellular carcinoma? A dosimetric comparison of spot-scanning proton therapy versus intensity-modulated radiation therapy","volume":"8","author":"Toramatsu","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0013","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1186\/1748-717X-8-250","article-title":"High-dose stereotactic body radiotherapy correlates increased local control and overall survival in patients with inoperable hepatocellular carcinoma","volume":"8","author":"Jang","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0014","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.meddos.2007.04.008","article-title":"Proton radiotherapy for liver tumors: Dosimetric advantages over photon plans","volume":"33","author":"Wang","year":"2008","journal-title":"Med Dosim"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0015","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1186\/s12885-016-2894-9","article-title":"Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm","volume":"16","author":"Su","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0016","doi-asserted-by":"crossref","first-page":"22","DOI":"10.21037\/tgh.2017.03.13","article-title":"Liver resection for hepatocellular carcinoma \u22655 cm","volume":"2","author":"Ettorre","year":"2017","journal-title":"Transl Gastroenterol Hepatol"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0017","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ijrobp.2019.02.032","article-title":"Predictors of radiation-induced liver disease in Eastern and Western patients with hepatocellular carcinoma undergoing proton beam therapy","volume":"105","author":"Hsieh","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0018","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.radonc.2007.12.009","article-title":"4D-CT imaging with synchronized intravenous contrast injection to improve delineation of liver tumors for treatment planning","volume":"87","author":"Beddar","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0019","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijrobp.2008.04.054","article-title":"Improving soft-tissue contrast in four-dimensional computed tomography images of liver cancer patients using a deformable image registration method","volume":"72","author":"Wang","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0020","doi-asserted-by":"crossref","first-page":"109891","DOI":"10.1016\/j.radonc.2023.109891","article-title":"A multicenter retrospective analysis of patients with salivary gland carcinoma treated with postoperative radiotherapy alone or chemoradiotherapy","volume":"188","author":"Hsieh","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0021","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.ijrobp.2010.07.015","article-title":"Proton beam therapy for hepatocellular carcinoma: A comparison of three treatment protocols","volume":"81","author":"Mizumoto","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0022","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.radonc.2018.10.041","article-title":"Proton beam therapy outcomes for localized unresectable hepatocellular carcinoma","volume":"133","author":"Chadha","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0023","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s13566-015-0195-6","article-title":"Liver dosimetric evaluation in biologically based stereotactic body radiotherapy for large inoperable hepatocellular carcinoma","volume":"4","author":"Loewen","year":"2015","journal-title":"J Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0024","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/S0360-3016(02)02846-8","article-title":"Analysis of radiation-induced liver disease using the Lyman NTCP model","volume":"53","author":"Dawson","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0025","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.1840210515","article-title":"Calculation of child and adult standard liver volume for liver transplantation","volume":"21","author":"Urata","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0026","first-page":"303","article-title":"A formula to estimate the approximate surface area if height and weight be known. 1916","volume":"5","author":"Du Bois","year":"1989","journal-title":"Nutrition"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0027","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00066-013-0343-0","article-title":"Predictive factors for gastroduodenal toxicity based on endoscopy following radiotherapy in patients with hepatocellular carcinoma","volume":"189","author":"Yoon","year":"2013","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0028","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.radonc.2022.10.019","article-title":"Lymphocyte sparing normal tissue effects in the clinic (LymphoTEC): A systematic review of dose constraint considerations to mitigate radiation-related lymphopenia in the era of immunotherapy","volume":"177","author":"Venkatesulu","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0029","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.2217\/fon-2021-0483","article-title":"A systematic review and meta-analysis of the impact of radiation-related lymphopenia on outcomes in pancreatic cancer","volume":"18","author":"Venkatesulu","year":"2022","journal-title":"Future Oncol"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0030","first-page":"83","article-title":"Splenic irradiation contributes to grade \u2265 3 lymphopenia after adjuvant chemoradiation for stomach cancer","volume":"36","author":"Lee","year":"2022","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0031","doi-asserted-by":"crossref","DOI":"10.21037\/tro.2018.09.02","article-title":"Complete response of unresectable icteric-type hepatocellular carcinoma to hypofractionated proton beam therapy with concurrent plus adjuvant sorafenib: a case report","volume":"2","author":"Hsieh","year":"2018","journal-title":"Ther Radiol Oncol"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0032","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1200\/JCO.2012.44.1659","article-title":"Sequential phase I and II trials of stereotactic body radiotherapy for locally advanced hepatocellular carcinoma","volume":"31","author":"Bujold","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0033","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.ijrobp.2022.09.002","article-title":"NRG\/RTOG 1112: Randomized phase III study of Sorafenib vs. Stereotactic Body Radiation therapy (SBRT) followed by Sorafenib in Hepatocellular Carcinoma (HCC) (NCT01730937)","volume":"114","author":"Dawson","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0034","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"Modified RECIST (mRECIST) assessment for hepatocellular carcinoma","volume":"30","author":"Lencioni","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0035","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3389\/fonc.2020.00542","article-title":"Phase II study of hypofractionated proton beam therapy for hepatocellular carcinoma","volume":"10","author":"Kim","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0036","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1053-4296(03)00031-6","article-title":"CTCAE v3.0: Development of a comprehensive grading system for the adverse effects of cancer treatment","volume":"13","author":"Trotti","year":"2003","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0037","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.ijrobp.2009.02.030","article-title":"Proton beam therapy for large hepatocellular carcinoma","volume":"76","author":"Sugahara","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0038","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1111\/hepr.12874","article-title":"Clinical results of proton beam therapy for hepatocellular carcinoma over 5 cm","volume":"47","author":"Kimura","year":"2017","journal-title":"Hepatol Res"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0039","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijrobp.2019.01.076","article-title":"Protons versus photons for unresectable hepatocellular carcinoma: Liver decompensation and overall survival","volume":"105","author":"Sanford","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0040","first-page":"39","article-title":"Definitive radiation therapy for hepatocellular carcinoma with portal vein tumor thrombus","volume":"4","author":"Holliday","year":"2017","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0041","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.3109\/0284186X.2011.592147","article-title":"Radiation treatment outcomes for unresectable hepatocellular carcinoma","volume":"50","author":"Skinner","year":"2011","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0042","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/cam4.1948","article-title":"Stereotactic body radiation therapy for hepatocellular carcinoma: Practice patterns, dose selection and factors impacting survival","volume":"8","author":"Robbins","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0043","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1007\/s00432-018-2729-y","article-title":"Stereotactic body radiation therapy for centrally located hepatocellular carcinoma: Outcomes and toxicities","volume":"144","author":"Lazarev","year":"2018","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0044","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13014-017-0851-7","article-title":"Excellent local control and tolerance profile after stereotactic body radiotherapy of advanced hepatocellular carcinoma","volume":"12","author":"Gkika","year":"2017","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177793","article-title":"Survival and prognostic factors for patients with advanced hepatocellular carcinoma after stereotactic ablative radiotherapy","volume":"12","author":"Lo","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0046","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00066-012-0298-6","article-title":"Radiotherapy with volumetric modulated arc therapy for hepatocellular carcinoma patients ineligible for surgery or ablative treatments","volume":"189","author":"Wang","year":"2013","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0047","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/jrr\/rrw028","article-title":"Efficacy of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein tumor thrombosis\/inferior vena cava tumor thrombosis: Evaluation by comparison with conventional three-dimensional conformal radiotherapy","volume":"57","author":"Matsuo","year":"2016","journal-title":"J Radiat Res"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0048","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20150945","article-title":"Three-dimensional conformal radiotherapy for locally advanced hepatocellular carcinoma with portal vein tumour thrombosis: Evaluating effectiveness of the model for end-stage liver disease (MELD) score compared with the Child-Pugh classification","volume":"89","author":"Okazaki","year":"2016","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0049","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/j.ijrobp.2004.05.048","article-title":"Biologic susceptibility of hepatocellular carcinoma patients treated with radiotherapy to radiation-induced liver disease","volume":"60","author":"Cheng","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0050","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ijrobp.2006.08.015","article-title":"Dose-volumetric parameters predicting radiation-induced hepatic toxicity in unresectable hepatocellular carcinoma patients treated with three-dimensional conformal radiotherapy","volume":"67","author":"Kim","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0051","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1053\/jlts.2002.31654","article-title":"Body surface area and body weight predict total liver volume in Western adults","volume":"8","author":"Vauthey","year":"2002","journal-title":"Liver Transpl"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0052","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1748-717X-8-11","article-title":"Dosimetric parameter predicting the deterioration of hepatic function after helical tomotherapy in patients with unresectable locally advanced hepatocellular carcinoma","volume":"8","author":"Son","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0053","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0168-8278(01)68827-5","article-title":"Predictors of morbidity and mortality after the first episode of upper gastrointestinal bleeding in liver cirrhosis","volume":"32","author":"del Olmo","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0054","doi-asserted-by":"crossref","first-page":"e469","DOI":"10.1016\/j.ijrobp.2012.06.005","article-title":"Predictor of severe gastroduodenal toxicity after stereotactic body radiotherapy for abdominopelvic malignancies","volume":"84","author":"Bae","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0055","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2147\/JHC.S282062","article-title":"Radiation-associated lymphopenia and outcomes of patients with unresectable hepatocellular carcinoma treated with radiotherapy","volume":"8","author":"De","year":"2021","journal-title":"J Hepatocell Carcinoma"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0056","doi-asserted-by":"crossref","first-page":"eabl9330","DOI":"10.1126\/sciimmunol.abl9330","article-title":"ATR-mediated CD47 and PD-L1 up-regulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer","volume":"7","author":"Hsieh","year":"2022","journal-title":"Sci Immunol"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0057","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ijrobp.2016.10.046","article-title":"Does unintentional splenic radiation predict outcomes after pancreatic cancer radiation therapy?","volume":"97","author":"Chadha","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0058","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.radonc.2018.12.001","article-title":"Lymphocyte nadir predicts tumor response and survival in locally advanced rectal cancer after neoadjuvant chemoradiotherapy: Immunologic relevance","volume":"131","author":"Liu","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0059","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ijrobp.2019.06.007","article-title":"First do no harm: How to prevent liver decompensation after radiation therapy for hepatocellular carcinoma","volume":"105","author":"Wojcieszynski","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0060","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1200\/JCO.2015.64.2710","article-title":"Multi-institutional phase II study of high-dose hypofractionated proton beam therapy in patients with localized, unresectable hepatocellular carcinoma and intrahepatic cholangiocarcinoma","volume":"34","author":"Hong","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2023.09.049_bib0061","doi-asserted-by":"crossref","first-page":"e529","DOI":"10.1016\/j.ijrobp.2011.05.056","article-title":"Evaluation of liver function after proton beam therapy for hepatocellular carcinoma","volume":"82","author":"Mizumoto","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301623079683?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301623079683?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T10:09:31Z","timestamp":1759745371000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301623079683"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0360301623079683"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2023.09.049","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and Dosimetric Results of Proton or Photon Radiation Therapy for Large (>5 cm) Hepatocellular Carcinoma: A Retrospective Analysis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2023.09.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}